Contraindicated in:
Use Cautiously in:
Derm: psoriasis, rash.
EENT: rhinitis, pharyngitis.
GI: abdominal pain, dyspepsia.
Hemat: pancytopenia.
Local: injection site reactions.
Neuro: headache, dizziness, weakness.
Resp: upper respiratory tract infection, cough, respiratory disorder.
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS), INFECTION (INCLUDING REACTIVATION TUBERCULOSIS AND OTHER OPPORTUNISTIC INFECTIONS DUE TO BACTERIAL, INVASIVE FUNGAL, VIRAL, MYCOBACTERIAL, AND PARASITIC PATHOGENS), MALIGNANCY (INCLUDING LYMPHOMA, HSTCL, LEUKEMIA, AND SKIN CANCER), SARCOIDOSIS.
Drug-Drug:
Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Plaque Psoriasis
Juvenile Idiopathic Arthritis
Absorption: 60% absorbed after SUBQ administration.
Distribution: Unknown.
Metabolism/Excretion: Unknown.
Half-life: 115 hr (range 98300 hr).
NDC Code*